Form 8-K - Current report:
SEC Accession No. 0001193125-20-074867
Filing Date
2020-03-16
Accepted
2020-03-16 16:08:32
Documents
4
Period of Report
2020-03-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d884510d8k.htm 8-K 16231
2 EX-99.1 d884510dex991.htm EX-99.1 21190
3 EX-99.2 d884510dex992.htm EX-99.2 21083
4 GRAPHIC g884510g46e58.jpg GRAPHIC 3409
  Complete submission text file 0001193125-20-074867.txt   64562
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 20717183
SIC: 2836 Biological Products, (No Diagnostic Substances)